Log in
Forgot password ?
Become a member for free
Sign up
Sign up
Dynamic quotes 

MarketScreener Homepage  >  News  >  Business Leaders  >  Business Leaders Biography

Business Leaders

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance ProfessionalsCalendarSectors 
HomeAll newsMost read newsBusiness Leaders Biography
Portrait de Barry Greene
Age : 55
Public asset : 4,776,303 USD
Country of residence : Unknown
Linked companies : Alnylam Pharmaceuticals, Inc. - Karyopharm Therapeutics Inc - Acorda Therapeutics Inc

Barry E. Greene occupies the position of President of Alnylam Pharmaceuticals, Inc. Dr. Greene is also on the board of Acorda Therapeutics, Inc. and Karyopharm Therapeutics, Inc. and Chief Medical Officer at Vicarious Surgical, Inc.

In his past career he was Partner at Andersen Consulting LLP (GB), Vice President-Marketing & Customer Services at AstraZeneca Plc and Vice President-Strategic Integration at AstraZeneca Pharmaceuticals LP (a subsidiary of AstraZeneca Plc), General Manager-Oncology Division at Takeda Oncology Co., Chief Business Officer & Executive Vice President at Mediconsult.com, Inc. and Partner at Accenture Ltd.

He received an undergraduate degree from the University of Pittsburgh.

Current positions of Barry Greene 
NameTitle Since
Alnylam Pharmaceuticals, Inc.
(Biotechnology & Medical Research)
President 2003
Karyopharm Therapeutics Inc
(Biotechnology & Medical Research)
Independent Director 2013
Acorda Therapeutics Inc
(Biotechnology & Medical Research)
Independent Director 2007
Vicarious Surgical, Inc. Chief Medical Officer -

Holdings of Barry Greene 
Alnylam Pharmaceuticals, Inc. (ALNY)
Biotechnology & Medical Research
64,8520.064%4,728,359 USD
Karyopharm Therapeutics Inc (KPTI)
Biotechnology & Medical Research
3,0000.0049%28,110 USD
Acorda Therapeutics Inc (ACOR)
Biotechnology & Medical Research
1,2730.0027%19,833 USD

Barry Greene : Personal Network 

Most Read News 
09/11CARLOS GHOSN : Nissan Management Withholds Full Ghosn Report From Board
09/10JACK MA : Tearful Ma bids Alibaba farewell with rock star show
09/11MARTIN SORRELL : Account wins put Sorrell's S4 Capital on course to double in size
09/12JEFF BEZOS : Three U.S. senators urge Amazon's Bezos to check driver abuse
09/14TIM COOK : Disney Chief Iger Quits Apple's Board -- WSJ
06:43pDAVID HENRY : U.S. bankers seize on repo-market stress to push for softer liquidity rules
09/11THOMAS BOONE PICKENS : 'Oracle of oil' T. Boone Pickens dies at 91
09/12MARTIN BOUYGUES : Alstom shares slide as top shareholder Bouygues cuts stake
09/12HIROTO SAIKAWA : Departure of Nissan's Saikawa hastened by independent directors - sources
09/17DANIEL LOEB : Sony rejects Loeb's proposal for chip business spin-off
More news

© 2019 People and Ownership :   
Barry Greene : Connections 
Labcyte, Inc.
Bay Way Consultants LLC
Biopharm Physicians LLC
Target Discovery, Inc.
Oscient Pharmaceuticals Corp.
Arcus Ventures
Cross Atlantic Partners, Inc.
Sapphire Digital
GQ Life Sciences, Inc.
Neuronetworks Fund

Latest news about Barry Greene 
2014ALNYLAM PHARMACEUTICALS, INC. : Sanofi to buy 12 percent of Alnylam, expands rare-disease drug deal
More news

Popular Business Leaders 
Bernard Arnault Jeff Bezos Thierry Bolloré Martin Bouygues Olivier Brandicourt Richard Branson Warren Buffett Tim Cook Benjamin De Rothschild Michael Dell Herbert Diess Jack Dorsey Patrick Drahi Sergio Ermotti Guillaume Faury Carlos Ghosn Philip Green David Henry Mark Hurd Carl Icahn Robert Iger Li Ka-shing Richard Li Daniel Loeb Jack Ma Ross Mcewan Lakshmi Mittal Rupert Murdoch Elon Musk Jean-pierre Mustier Jean-charles Naouri Michael O'leary Ferdinand Piëch Wolfgang Porsche Sumner Redstone Stéphane Richard Wilbur Ross Hiroto Saikawa Ann Sarnoff Charles Schwab Jean-dominique Senard Mark Smucker Masayoshi Son Friede Springer Rupert Stadler Bernard Tapie Carlos Tavares François Villeroy De Galhau Leslie Wexner Mark Zuckerberg
A-Z Business Leaders